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Background:  Severe aortic regurgitation (AR) is a contraindication for aortic balloon valvuloplasty (ABV). However, the effects of ABV in the 
presence of mild and moderate AR are unknown.
Methods:  The study included 263 consecutive patients with symptomatic severe aortic stenosis who were subjected to ABV. Patients were 
stratified into groups according to pre-procedure degree of AR assessed by echocardiogram available before the procedure. Patients received post-
ABV echocardiography and were followed for clinical events at 1 year.
Results:  The study groups included pre-ABV with no AR = 76 (29.9%), mild AR = 180 (68.3%), and moderate AR = 7 (2.7%). There were no 
differences in the baseline characteristics with a mean age of 81.9±9.4 and STS = 12.9±9. At 1 year, the rate of death was 41.1% in patients with 
no AR, 46.9% in patients with mild AR, and 63.6% in patients with moderate AR respectively, p = 0.31. The number of patients post-ABV with no AR 
decreased to 43 (16.3%), and increased in the mild AR to 206 (78.3%) and moderate AR to 14 (5.4%), p = 0.0009. The proportion of patients with 
no AR pre-ABV who developed mild AR post-ABV was 48.7%, and the proportion with mild AR pre-ABV who developed moderate AR post-ABV was 
4.5%, all p <0.001, table. Two patients developed severe AR post-ABV.
Conclusion: It is safe to perform ABV in patients with mild and moderate AR. Half the patients with no AR may develop mild AR and a small 
percentage with mild AR will develop moderate AR post-ABV. This result needs to be confirmed in other studies. 
